All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Does TRT actually cause or worsen snoring and sleep apnea?

cbronsonMD

TikTok creator

4.7K viewsWatch on TikTok→

Quick answer

Testosterone replacement therapy is associated with worsening of both obstructive and central sleep apnea, particularly in the early months of treatment, due to androgen-related reductions in hypoxic ventilatory response and upper airway muscle tone. The creator references a transient central sleep apnea component that may resolve around four months, which has some clinical basis but is not a universal or reliable outcome across patient populations. Patients starting TRT who develop new or worsening snoring, daytime fatigue, or witnessed apneas should be referred for formal polysomnography rather than watchful waiting.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @cbronsonmd actually say?

The claim is specific: TRT can worsen obstructive sleep apnea early on, causes "a component of central sleep apnea that goes away after about four months," and there are "two studies" supporting this. He also dismisses CPAP as intimacy-killing and endorses mandibular advancement devices (MADs) as equally effective. That is a lot of ground to cover in a short clip, and some of it holds up better than others.

He is speaking from personal experience as much as from clinical knowledge. He threw his CPAP in the dumpster. His ex-girlfriend may have accidentally discarded his MAD. This is either refreshingly honest or a red flag about his compliance counseling, depending on your perspective.

Does the science back this up?

Partially, yes. The testosterone-sleep apnea link is real and reasonably well-documented. Testosterone is known to reduce hypoxic ventilatory response and can suppress upper airway muscle tone, which worsens both obstructive and central sleep apnea. The claim about central sleep apnea being a transient early effect has some support, but "two studies" is doing heavy lifting here.

A study by Hoyos et al. (2012, European Journal of Endocrinology) found that testosterone therapy worsened sleep-disordered breathing in obese men with low testosterone. Cistulli and colleagues have documented the relationship between androgens and upper airway collapsibility for years. The transient central apnea component is referenced in clinical literature, but the "gone by four months" timeline is not as clean or universal as he implies. Some patients see persistent worsening. The evidence is suggestive, not settled.

What did they get wrong (or right)?

He gets credit for flagging the TRT-sleep apnea connection at all. Most TRT content on TikTok ignores this entirely. The warning to get a sleep study is genuinely good advice.

Where he goes sideways is the MAD claim. He says it "worked just as well" as CPAP. That is not what the evidence shows at a population level. A Cochrane review (Lim et al., 2006) and subsequent meta-analyses consistently show CPAP is superior to MADs for reducing apnea-hypopnea index (AHI), particularly in moderate-to-severe OSA. MADs are a legitimate alternative for mild-to-moderate cases or for patients who cannot tolerate CPAP, but "just as well" oversimplifies a real distinction. His personal experience is not a clinical trial.

The CPAP-kills-intimacy framing is also worth pushing back on. Untreated sleep apnea is associated with cardiovascular risk, erectile dysfunction, and daytime cognitive impairment. That kills intimacy too, just more slowly.

What should you actually know?

If you started TRT and your snoring or fatigue has gotten worse, a sleep study is the right move. Full stop. The early worsening of sleep-disordered breathing on TRT is a real phenomenon, and it is underscreened.

What you should not do is assume it will resolve on its own by month four and skip the workup. The transient central apnea data applies to a specific subset of patients, and obstructive apnea does not follow the same timeline. A sleep physician, not a TikTok video, should interpret your results.

  • CPAP remains the gold-standard treatment for moderate-to-severe OSA. Do not throw it in the dumpster based on one night.
  • MADs are a valid option for mild-to-moderate OSA or confirmed CPAP intolerance, but efficacy varies by anatomy and severity.
  • Newer CPAP alternatives like positional therapy devices and hypoglossal nerve stimulation (Inspire) exist for patients who genuinely cannot tolerate masks.
  • If you are on TRT, baseline sleep screening before initiation is worth discussing with your prescriber, especially if you have risk factors like obesity, a large neck circumference, or prior snoring.

Bottom line: should you trust this advice?

Trust the warning about TRT and sleep apnea. That part is grounded in real physiology and real studies. Be skeptical of the "four months and it disappears" timeline applied universally. Be more skeptical of the MAD-equals-CPAP claim. And please do not model your medical compliance on someone who describes throwing prescribed equipment into a dumpster the night after trying it once.

He is raising a legitimately undertalked issue. He is just wrapping it in anecdote in ways that could lead patients to undertreat a condition that has serious downstream consequences.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Does TRT actually cause or worsen snoring and sleep apnea?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Does TRT actually cause or worsen snoring and sleep apnea? is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Testosterone replacement therapy is associated with worsening of both obstructive and central sleep apnea, particularly in the early months of treatment, due to androgen-related reductions in hypoxic ventilatory response and upper airway muscle tone.

FormBlends verdict

Testosterone replacement therapy is associated with worsening of both obstructive and central sleep apnea, particularly in the early months of treatment, due to androgen-related reductions in hypoxic ventilatory response and upper airway muscle tone. The creator references a transient central sleep apnea component that may resolve around four months, which has some clinical basis but is not a universal or reliable outcome across patient populations. Patients starting TRT who develop new or worsening snoring, daytime fatigue, or witnessed apneas should be referred for formal polysomnography rather than watchful waiting.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone replacement therapy is associated with worsening of both obstructive and central sleep apnea, particularly in the early months of treatment, due to androgen-related reductions in hypoxic ventilatory response and upper airway muscle tone. The creator references a transient central sleep apnea component that may resolve around four months, which has some clinical basis but is not a universal or reliable outcome across patient populations. Patients starting TRT who develop new or worsening snoring, daytime fatigue, or witnessed apneas should be referred for formal polysomnography rather than watchful waiting.
  • Testosterone therapy is associated with worsening sleep-disordered breathing, including both obstructive and central components, a finding supported by multiple endocrinology studies including Hoyos et al. (2012).
  • A transient central sleep apnea component early in TRT has some clinical basis, but the four-month resolution window is not universal and should not be used to justify skipping a sleep study.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone therapy is associated with worsening sleep-disordered breathing, including both obstructive and central components, a finding supported by multiple endocrinology studies including Hoyos et al. (2012).
  • A transient central sleep apnea component early in TRT has some clinical basis, but the four-month resolution window is not universal and should not be used to justify skipping a sleep study.
  • CPAP remains superior to mandibular advancement devices for moderate-to-severe OSA based on meta-analytic data; MADs are appropriate for mild-to-moderate cases or documented CPAP intolerance.
  • CPAP non-adherence affects roughly 30-50% of patients at one year, but discarding the device after one night forecloses acclimatization, mask adjustment, and auto-titration options that improve tolerance.
  • Untreated obstructive sleep apnea carries cardiovascular, metabolic, and sexual health risks that compound over time, including risks directly relevant to men seeking TRT for low energy or low libido.
  • Men beginning TRT with obesity, large neck circumference, or prior snoring history should discuss baseline sleep screening with their prescriber before or shortly after initiation.
  • Hypoglossal nerve stimulation (Inspire) and positional therapy devices are additional options for patients with confirmed CPAP intolerance, options not mentioned in this video.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

cbronsonMD · TikTok creator

4.7K views on this video

Snoring like a pig on TRT? #trt #testosterone #testosteronetherapy

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by cbronsonMD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.